Free Trial

Tenet Healthcare (THC) Stock Price, News & Analysis

$153.40
-8.58 (-5.30%)
(As of 09/6/2024 ET)
Today's Range
$150.12
$163.61
50-Day Range
$129.27
$165.85
52-Week Range
$51.04
$166.89
Volume
2.24 million shs
Average Volume
1.21 million shs
Market Capitalization
$14.98 billion
P/E Ratio
5.95
Dividend Yield
N/A
Price Target
$152.69

Tenet Healthcare MarketRank™ Stock Analysis

Analyst Rating
Buy
3.06 Rating Score
Upside/​Downside
0.5% Downside
$152.69 Price Target
Short Interest
Healthy
3.53% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.90
Upright™ Environmental Score
News Sentiment
1.09mentions of Tenet Healthcare in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$19.94 M Sold Last Quarter
Proj. Earnings Growth
1.12%
From $10.70 to $10.82 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.59 out of 5 stars

Medical Sector

75th out of 910 stocks

General Medical & Surgical Hospitals Industry

3rd out of 5 stocks

THC stock logo

About Tenet Healthcare Stock (NYSE:THC)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.

THC Stock Price History

THC Stock News Headlines

“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Stethoscope and digital tablet — Photo
Tenet Healthcare Stock Sees Strong Gains from Acute Care Boom
Hospital and ambulatory care operator Tenet Healthcare Co. (NYSE: THC) is operating in the sweet spot of healthcare these days.
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines
Receive THC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenet Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/24/2024
Today
9/07/2024
Next Earnings (Estimated)
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Health Care Facilities
CUSIP
88033G40
Employees
106,500
Year Founded
1969

Price Target and Rating

Average Stock Price Target
$152.69
High Stock Price Target
$197.00
Low Stock Price Target
$85.00
Potential Upside/Downside
-0.5%
Consensus Rating
Buy
Rating Score (0-4)
3.06
Research Coverage
17 Analysts

Profitability

Net Income
$611 million
Pretax Margin
21.68%

Debt

Sales & Book Value

Annual Sales
$20.92 billion
Cash Flow
$15.00 per share
Book Value
$52.76 per share

Miscellaneous

Free Float
96,775,000
Market Cap
$14.98 billion
Optionable
Optionable
Beta
2.14

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives


THC Stock Analysis - Frequently Asked Questions

How have THC shares performed this year?

Tenet Healthcare's stock was trading at $75.57 on January 1st, 2024. Since then, THC shares have increased by 103.0% and is now trading at $153.40.
View the best growth stocks for 2024 here
.

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare Co. (NYSE:THC) released its quarterly earnings results on Wednesday, July, 24th. The company reported $2.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.42. The company earned $5.10 billion during the quarter, compared to analysts' expectations of $4.98 billion. Tenet Healthcare had a trailing twelve-month return on equity of 24.66% and a net margin of 13.17%.

Is Tenet Healthcare doing a stock buyback?

Tenet Healthcare's board initiated a stock repurchase program on Wednesday, July 24th 2024, which permits the company to buy back $1,500,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 10.3% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's management believes its shares are undervalued.

What is Ronald A. Rittenmeyer's approval rating as Tenet Healthcare's CEO?

133 employees have rated Tenet Healthcare Chief Executive Officer Ronald A. Rittenmeyer on Glassdoor.com. Ronald A. Rittenmeyer has an approval rating of 34% among the company's employees. This puts Ronald A. Rittenmeyer in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Does Tenet Healthcare have any subsidiaries?

Tenet Healthcare subsidiaries include SurgCenter Development, United Surgical Partners International, European Surgical Partners Ltd., Aspen Healthcare, Emanuel Medical Center, Texas Regional Medical in Sunnyvale, Vanguard Health Systems, and more.

Who are Tenet Healthcare's major shareholders?

Top institutional shareholders of Tenet Healthcare include Dimensional Fund Advisors LP (1.34%), Bank of New York Mellon Corp (0.94%), Marshall Wace LLP (0.73%) and Farallon Capital Management LLC (0.70%). Insiders that own company stock include Daniel J Cancelmi, Tammy Romo, J Robert Kerrey, Richard J Mark, Nadja West, Paola M Arbour, Meghan Fitzgerald, Christopher S Lynch, Richard W Fisher, Saumya Sutaria, R Scott Ramsey, Thomas W Arnst, Ronald A Rittenmeyer and Audrey T Andrews.
View institutional ownership trends
.

How do I buy shares of Tenet Healthcare?

Shares of THC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Tenet Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tenet Healthcare investors own include Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA), Walt Disney (DIS), General Electric (GE), Delta Air Lines (DAL) and Bank of America (BAC).

This page (NYSE:THC) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners